Providence Therapeutics
Bradley Sorenson has been involved in the biotechnology industry since 2015, when they were appointed President & CEO of Providence Therapeutics. Bradley then went on to become Co-founder of Arcturus Therapeutics.
Bradley Sorenson has attended the University of Chicago (UofC).
Providence Therapeutics
1 followers
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.